Pages that link to "Q30385999"
Jump to navigation
Jump to search
The following pages link to Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge. (Q30385999):
Displaying 29 items.
- A model for early onset of protection against lethal challenge with highly pathogenic H5N1 influenza virus. (Q30360697) (← links)
- A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine. (Q30370147) (← links)
- Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice (Q30375073) (← links)
- Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains. (Q30382576) (← links)
- Viral vector-based influenza vaccines (Q30390938) (← links)
- New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges (Q30407424) (← links)
- A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination (Q30418715) (← links)
- Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model (Q30420397) (← links)
- Immunobiology of influenza vaccines (Q30426771) (← links)
- Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses (Q30427591) (← links)
- Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors (Q33936327) (← links)
- Virus-vectored influenza virus vaccines (Q34102268) (← links)
- Influenza Vaccines for the Future (Q34150283) (← links)
- Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma (Q34198856) (← links)
- Vesicular stomatitis virus-based H5N1 avian influenza vaccines induce potent cross-clade neutralizing antibodies in rhesus macaques (Q35076920) (← links)
- Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy (Q35077419) (← links)
- The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site (Q35212733) (← links)
- Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus (Q35531542) (← links)
- Progress in filovirus vaccine development: evaluating the potential for clinical use. (Q36100545) (← links)
- Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins (Q36791009) (← links)
- Cross-protection of newly emerging HPAI H5 viruses by neutralizing human monoclonal antibodies: A viable alternative to oseltamivir (Q37141589) (← links)
- Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters (Q37611811) (← links)
- VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications. (Q37714030) (← links)
- Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents (Q40193887) (← links)
- Signaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin (Q41820076) (← links)
- The synthetic futures of vesicular stomatitis virus. (Q45356237) (← links)
- Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil". (Q54378300) (← links)
- Reverse Genetics of Rhabdoviruses (Q57077874) (← links)
- A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades (Q92620046) (← links)